Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and Antagonist. 2020

James S Scott, and Thomas A Moss, and Amber Balazs, and Bernard Barlaam, and Jason Breed, and Rodrigo J Carbajo, and Elisabetta Chiarparin, and Paul R J Davey, and Oona Delpuech, and Stephen Fawell, and David I Fisher, and Sladjana Gagrica, and Eric T Gangl, and Tyler Grebe, and Ryan D Greenwood, and Sudhir Hande, and Holia Hatoum-Mokdad, and Kara Herlihy, and Samantha Hughes, and Thomas A Hunt, and Hoan Huynh, and Sophie L M Janbon, and Tony Johnson, and Stefan Kavanagh, and Teresa Klinowska, and Mandy Lawson, and Andrew S Lister, and Stacey Marden, and Dermot F McGinnity, and Christopher J Morrow, and J Willem M Nissink, and Daniel H O'Donovan, and Bo Peng, and Radoslaw Polanski, and Darren S Stead, and Stephen Stokes, and Kumar Thakur, and Scott R Throner, and Michael J Tucker, and Jeffrey Varnes, and Haixia Wang, and David M Wilson, and Dedong Wu, and Ye Wu, and Bin Yang, and Wenzhan Yang
Oncology R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom.

Herein we report the optimization of a series of tricyclic indazoles as selective estrogen receptor degraders (SERD) and antagonists for the treatment of ER+ breast cancer. Structure based design together with systematic investigation of each region of the molecular architecture led to the identification of N-[1-(3-fluoropropyl)azetidin-3-yl]-6-[(6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl]pyridin-3-amine (28). This compound was demonstrated to be a highly potent SERD that showed a pharmacological profile comparable to fulvestrant in its ability to degrade ERα in both MCF-7 and CAMA-1 cell lines. A stringent control of lipophilicity ensured that 28 had favorable physicochemical and preclinical pharmacokinetic properties for oral administration. This, combined with demonstration of potent in vivo activity in mouse xenograft models, resulted in progression of this compound, also known as AZD9833, into clinical trials.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003500 Cyclization Changing an open-chain hydrocarbon to a closed ring. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Cyclizations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

James S Scott, and Thomas A Moss, and Amber Balazs, and Bernard Barlaam, and Jason Breed, and Rodrigo J Carbajo, and Elisabetta Chiarparin, and Paul R J Davey, and Oona Delpuech, and Stephen Fawell, and David I Fisher, and Sladjana Gagrica, and Eric T Gangl, and Tyler Grebe, and Ryan D Greenwood, and Sudhir Hande, and Holia Hatoum-Mokdad, and Kara Herlihy, and Samantha Hughes, and Thomas A Hunt, and Hoan Huynh, and Sophie L M Janbon, and Tony Johnson, and Stefan Kavanagh, and Teresa Klinowska, and Mandy Lawson, and Andrew S Lister, and Stacey Marden, and Dermot F McGinnity, and Christopher J Morrow, and J Willem M Nissink, and Daniel H O'Donovan, and Bo Peng, and Radoslaw Polanski, and Darren S Stead, and Stephen Stokes, and Kumar Thakur, and Scott R Throner, and Michael J Tucker, and Jeffrey Varnes, and Haixia Wang, and David M Wilson, and Dedong Wu, and Ye Wu, and Bin Yang, and Wenzhan Yang
April 2018, Journal of medicinal chemistry,
James S Scott, and Thomas A Moss, and Amber Balazs, and Bernard Barlaam, and Jason Breed, and Rodrigo J Carbajo, and Elisabetta Chiarparin, and Paul R J Davey, and Oona Delpuech, and Stephen Fawell, and David I Fisher, and Sladjana Gagrica, and Eric T Gangl, and Tyler Grebe, and Ryan D Greenwood, and Sudhir Hande, and Holia Hatoum-Mokdad, and Kara Herlihy, and Samantha Hughes, and Thomas A Hunt, and Hoan Huynh, and Sophie L M Janbon, and Tony Johnson, and Stefan Kavanagh, and Teresa Klinowska, and Mandy Lawson, and Andrew S Lister, and Stacey Marden, and Dermot F McGinnity, and Christopher J Morrow, and J Willem M Nissink, and Daniel H O'Donovan, and Bo Peng, and Radoslaw Polanski, and Darren S Stead, and Stephen Stokes, and Kumar Thakur, and Scott R Throner, and Michael J Tucker, and Jeffrey Varnes, and Haixia Wang, and David M Wilson, and Dedong Wu, and Ye Wu, and Bin Yang, and Wenzhan Yang
June 2011, ACS medicinal chemistry letters,
James S Scott, and Thomas A Moss, and Amber Balazs, and Bernard Barlaam, and Jason Breed, and Rodrigo J Carbajo, and Elisabetta Chiarparin, and Paul R J Davey, and Oona Delpuech, and Stephen Fawell, and David I Fisher, and Sladjana Gagrica, and Eric T Gangl, and Tyler Grebe, and Ryan D Greenwood, and Sudhir Hande, and Holia Hatoum-Mokdad, and Kara Herlihy, and Samantha Hughes, and Thomas A Hunt, and Hoan Huynh, and Sophie L M Janbon, and Tony Johnson, and Stefan Kavanagh, and Teresa Klinowska, and Mandy Lawson, and Andrew S Lister, and Stacey Marden, and Dermot F McGinnity, and Christopher J Morrow, and J Willem M Nissink, and Daniel H O'Donovan, and Bo Peng, and Radoslaw Polanski, and Darren S Stead, and Stephen Stokes, and Kumar Thakur, and Scott R Throner, and Michael J Tucker, and Jeffrey Varnes, and Haixia Wang, and David M Wilson, and Dedong Wu, and Ye Wu, and Bin Yang, and Wenzhan Yang
October 2021, Bioorganic & medicinal chemistry letters,
James S Scott, and Thomas A Moss, and Amber Balazs, and Bernard Barlaam, and Jason Breed, and Rodrigo J Carbajo, and Elisabetta Chiarparin, and Paul R J Davey, and Oona Delpuech, and Stephen Fawell, and David I Fisher, and Sladjana Gagrica, and Eric T Gangl, and Tyler Grebe, and Ryan D Greenwood, and Sudhir Hande, and Holia Hatoum-Mokdad, and Kara Herlihy, and Samantha Hughes, and Thomas A Hunt, and Hoan Huynh, and Sophie L M Janbon, and Tony Johnson, and Stefan Kavanagh, and Teresa Klinowska, and Mandy Lawson, and Andrew S Lister, and Stacey Marden, and Dermot F McGinnity, and Christopher J Morrow, and J Willem M Nissink, and Daniel H O'Donovan, and Bo Peng, and Radoslaw Polanski, and Darren S Stead, and Stephen Stokes, and Kumar Thakur, and Scott R Throner, and Michael J Tucker, and Jeffrey Varnes, and Haixia Wang, and David M Wilson, and Dedong Wu, and Ye Wu, and Bin Yang, and Wenzhan Yang
January 2024, Journal of medicinal chemistry,
James S Scott, and Thomas A Moss, and Amber Balazs, and Bernard Barlaam, and Jason Breed, and Rodrigo J Carbajo, and Elisabetta Chiarparin, and Paul R J Davey, and Oona Delpuech, and Stephen Fawell, and David I Fisher, and Sladjana Gagrica, and Eric T Gangl, and Tyler Grebe, and Ryan D Greenwood, and Sudhir Hande, and Holia Hatoum-Mokdad, and Kara Herlihy, and Samantha Hughes, and Thomas A Hunt, and Hoan Huynh, and Sophie L M Janbon, and Tony Johnson, and Stefan Kavanagh, and Teresa Klinowska, and Mandy Lawson, and Andrew S Lister, and Stacey Marden, and Dermot F McGinnity, and Christopher J Morrow, and J Willem M Nissink, and Daniel H O'Donovan, and Bo Peng, and Radoslaw Polanski, and Darren S Stead, and Stephen Stokes, and Kumar Thakur, and Scott R Throner, and Michael J Tucker, and Jeffrey Varnes, and Haixia Wang, and David M Wilson, and Dedong Wu, and Ye Wu, and Bin Yang, and Wenzhan Yang
August 2021, Journal of medicinal chemistry,
James S Scott, and Thomas A Moss, and Amber Balazs, and Bernard Barlaam, and Jason Breed, and Rodrigo J Carbajo, and Elisabetta Chiarparin, and Paul R J Davey, and Oona Delpuech, and Stephen Fawell, and David I Fisher, and Sladjana Gagrica, and Eric T Gangl, and Tyler Grebe, and Ryan D Greenwood, and Sudhir Hande, and Holia Hatoum-Mokdad, and Kara Herlihy, and Samantha Hughes, and Thomas A Hunt, and Hoan Huynh, and Sophie L M Janbon, and Tony Johnson, and Stefan Kavanagh, and Teresa Klinowska, and Mandy Lawson, and Andrew S Lister, and Stacey Marden, and Dermot F McGinnity, and Christopher J Morrow, and J Willem M Nissink, and Daniel H O'Donovan, and Bo Peng, and Radoslaw Polanski, and Darren S Stead, and Stephen Stokes, and Kumar Thakur, and Scott R Throner, and Michael J Tucker, and Jeffrey Varnes, and Haixia Wang, and David M Wilson, and Dedong Wu, and Ye Wu, and Bin Yang, and Wenzhan Yang
December 2011, ACS medicinal chemistry letters,
James S Scott, and Thomas A Moss, and Amber Balazs, and Bernard Barlaam, and Jason Breed, and Rodrigo J Carbajo, and Elisabetta Chiarparin, and Paul R J Davey, and Oona Delpuech, and Stephen Fawell, and David I Fisher, and Sladjana Gagrica, and Eric T Gangl, and Tyler Grebe, and Ryan D Greenwood, and Sudhir Hande, and Holia Hatoum-Mokdad, and Kara Herlihy, and Samantha Hughes, and Thomas A Hunt, and Hoan Huynh, and Sophie L M Janbon, and Tony Johnson, and Stefan Kavanagh, and Teresa Klinowska, and Mandy Lawson, and Andrew S Lister, and Stacey Marden, and Dermot F McGinnity, and Christopher J Morrow, and J Willem M Nissink, and Daniel H O'Donovan, and Bo Peng, and Radoslaw Polanski, and Darren S Stead, and Stephen Stokes, and Kumar Thakur, and Scott R Throner, and Michael J Tucker, and Jeffrey Varnes, and Haixia Wang, and David M Wilson, and Dedong Wu, and Ye Wu, and Bin Yang, and Wenzhan Yang
April 2010, ACS medicinal chemistry letters,
James S Scott, and Thomas A Moss, and Amber Balazs, and Bernard Barlaam, and Jason Breed, and Rodrigo J Carbajo, and Elisabetta Chiarparin, and Paul R J Davey, and Oona Delpuech, and Stephen Fawell, and David I Fisher, and Sladjana Gagrica, and Eric T Gangl, and Tyler Grebe, and Ryan D Greenwood, and Sudhir Hande, and Holia Hatoum-Mokdad, and Kara Herlihy, and Samantha Hughes, and Thomas A Hunt, and Hoan Huynh, and Sophie L M Janbon, and Tony Johnson, and Stefan Kavanagh, and Teresa Klinowska, and Mandy Lawson, and Andrew S Lister, and Stacey Marden, and Dermot F McGinnity, and Christopher J Morrow, and J Willem M Nissink, and Daniel H O'Donovan, and Bo Peng, and Radoslaw Polanski, and Darren S Stead, and Stephen Stokes, and Kumar Thakur, and Scott R Throner, and Michael J Tucker, and Jeffrey Varnes, and Haixia Wang, and David M Wilson, and Dedong Wu, and Ye Wu, and Bin Yang, and Wenzhan Yang
December 2010, Bioorganic & medicinal chemistry letters,
James S Scott, and Thomas A Moss, and Amber Balazs, and Bernard Barlaam, and Jason Breed, and Rodrigo J Carbajo, and Elisabetta Chiarparin, and Paul R J Davey, and Oona Delpuech, and Stephen Fawell, and David I Fisher, and Sladjana Gagrica, and Eric T Gangl, and Tyler Grebe, and Ryan D Greenwood, and Sudhir Hande, and Holia Hatoum-Mokdad, and Kara Herlihy, and Samantha Hughes, and Thomas A Hunt, and Hoan Huynh, and Sophie L M Janbon, and Tony Johnson, and Stefan Kavanagh, and Teresa Klinowska, and Mandy Lawson, and Andrew S Lister, and Stacey Marden, and Dermot F McGinnity, and Christopher J Morrow, and J Willem M Nissink, and Daniel H O'Donovan, and Bo Peng, and Radoslaw Polanski, and Darren S Stead, and Stephen Stokes, and Kumar Thakur, and Scott R Throner, and Michael J Tucker, and Jeffrey Varnes, and Haixia Wang, and David M Wilson, and Dedong Wu, and Ye Wu, and Bin Yang, and Wenzhan Yang
April 2017, Journal of medicinal chemistry,
James S Scott, and Thomas A Moss, and Amber Balazs, and Bernard Barlaam, and Jason Breed, and Rodrigo J Carbajo, and Elisabetta Chiarparin, and Paul R J Davey, and Oona Delpuech, and Stephen Fawell, and David I Fisher, and Sladjana Gagrica, and Eric T Gangl, and Tyler Grebe, and Ryan D Greenwood, and Sudhir Hande, and Holia Hatoum-Mokdad, and Kara Herlihy, and Samantha Hughes, and Thomas A Hunt, and Hoan Huynh, and Sophie L M Janbon, and Tony Johnson, and Stefan Kavanagh, and Teresa Klinowska, and Mandy Lawson, and Andrew S Lister, and Stacey Marden, and Dermot F McGinnity, and Christopher J Morrow, and J Willem M Nissink, and Daniel H O'Donovan, and Bo Peng, and Radoslaw Polanski, and Darren S Stead, and Stephen Stokes, and Kumar Thakur, and Scott R Throner, and Michael J Tucker, and Jeffrey Varnes, and Haixia Wang, and David M Wilson, and Dedong Wu, and Ye Wu, and Bin Yang, and Wenzhan Yang
December 2010, ACS medicinal chemistry letters,
Copied contents to your clipboard!